325 related articles for article (PubMed ID: 22420052)
1. Prevalence of otomycosis in Ibadan: a review of laboratory reports.
Fayemiwo SA; Ogunleye VO; Adeosun AA; Bakare RA
Afr J Med Med Sci; 2010 Dec; 39 Suppl():219-22. PubMed ID: 22420052
[TBL] [Abstract][Full Text] [Related]
2. The fungal profile of otomycosis patients in Ilorin, Nigeria.
Nwabuisi C; Ologe FE
Niger J Med; 2001; 10(3):124-6. PubMed ID: 11806011
[TBL] [Abstract][Full Text] [Related]
3. Otomycosis in western Nigeria.
Fasunla J; Ibekwe T; Onakoya P
Mycoses; 2008 Jan; 51(1):67-70. PubMed ID: 18076598
[TBL] [Abstract][Full Text] [Related]
4. Otomycosis: a clinicomycologic study.
Kaur R; Mittal N; Kakkar M; Aggarwal AK; Mathur MD
Ear Nose Throat J; 2000 Aug; 79(8):606-9. PubMed ID: 10969470
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of otomycosis in Khouzestan Province, south-west Iran.
Saki N; Rafiei A; Nikakhlagh S; Amirrajab N; Saki S
J Laryngol Otol; 2013 Jan; 127(1):25-7. PubMed ID: 23164073
[TBL] [Abstract][Full Text] [Related]
6. [Agents of otomycosis in Manisa region, Turkey, 1995-2011].
Değerli K; Ecemiş T; Günhan K; Başkesen T; Kal E
Mikrobiyol Bul; 2012 Jan; 46(1):79-84. PubMed ID: 22399174
[TBL] [Abstract][Full Text] [Related]
7. Fungal infection of the ear: a common problem in the north eastern part of Haryana.
Aneja KR; Sharma C; Joshi R
Int J Pediatr Otorhinolaryngol; 2010 Jun; 74(6):604-7. PubMed ID: 20347163
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiology of otomycoses at the University Hospital of Yopougon (Abidjan-Ivory Coast)].
Adoubryn KD; N'Gattia VK; Kouadio-Yapo GC; Nigué L; Zika DK; Ouhon J
J Mycol Med; 2014 Jun; 24(2):e9-15. PubMed ID: 24139621
[TBL] [Abstract][Full Text] [Related]
9. Species distribution patterns and epidemiological characteristics of otomycosis in Southeastern Serbia.
Tasić-Otašević S; Golubović M; Đenić S; Ignjatović A; Stalević M; Momčilović S; Bojanović M; Arsić-Arsenijević V
J Mycol Med; 2020 Sep; 30(3):101011. PubMed ID: 32693980
[TBL] [Abstract][Full Text] [Related]
10. Otomycosis in iran: a review.
Gharaghani M; Seifi Z; Zarei Mahmoudabadi A
Mycopathologia; 2015 Jun; 179(5-6):415-24. PubMed ID: 25633436
[TBL] [Abstract][Full Text] [Related]
11. Otomycosis in Shanghai: aetiology, clinical features and therapy.
Jia X; Liang Q; Chi F; Cao W
Mycoses; 2012 Sep; 55(5):404-9. PubMed ID: 21999222
[TBL] [Abstract][Full Text] [Related]
12. Clinical and microbial epidemiology of otomycosis in the city of Yasuj, southwest Iran, revealing Aspergillus tubingensis as the dominant causative agent.
Sabz G; Gharaghani M; Mirhendi H; Ahmadi B; Gatee MA; Sisakht MT; Hemati A; Mohammadi R; Taghavi J; Nouripour-Sisakht S
J Med Microbiol; 2019 Apr; 68(4):585-590. PubMed ID: 30801244
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Pradhan B; Tuladhar NR; Amatya RM
Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):384-7. PubMed ID: 12731637
[TBL] [Abstract][Full Text] [Related]
14. Concomitant otomycosis and dermatomycoses: a clinical and microbiological study.
Ozcan M; Ozcan KM; Karaarslan A; Karaarslan F
Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):24-7. PubMed ID: 12520352
[TBL] [Abstract][Full Text] [Related]
15. Role of Clotrimazole in Prevention of Recurrent Otomycosis.
Kiakojuri K; Rajabnia R; Mahdavi Omran S; Pournajaf A; Karami M; Taghizadeh Armaki M
Biomed Res Int; 2019; 2019():5269535. PubMed ID: 31950041
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence and risk factors for otomycosis treated in the hospital setting in Abidjan (Ivory Coast)].
Yavo W; Kassi RR; Kiki-Barro PC; Bamba A; Kplé T; Menan EI; Ehouo F; Koné M
Med Trop (Mars); 2004; 64(1):39-42. PubMed ID: 15224556
[TBL] [Abstract][Full Text] [Related]
17. Clinical and microbiological profile of otomycosis in Lagos, Nigeria.
Asoegwu CN; Oladele RO; Kanu OO; Peters RF; Nwawolo CC
Niger Postgrad Med J; 2023; 30(2):132-136. PubMed ID: 37148115
[TBL] [Abstract][Full Text] [Related]
18. [The modern algorithm for treatment and diagnostics of otomycosis].
Vestn Otorinolaringol; 2011; (6):109-12. PubMed ID: 22433709
[TBL] [Abstract][Full Text] [Related]
19. Otomycosis in Africa: Epidemiology, diagnosis and treatment.
Sangaré I; Amona FM; Ouedraogo RW; Zida A; Ouedraogo MS
J Mycol Med; 2021 Jun; 31(2):101115. PubMed ID: 33516991
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of otomycosis in Isfahan revealed a large diversity in causative agents.
Aboutalebian S; Mahmoudi S; Mirhendi H; Okhovat A; Abtahi H; Chabavizadeh J
J Med Microbiol; 2019 Jun; 68(6):918-923. PubMed ID: 31063125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
